VivoSeq
Oncology

Metastases

0

Pipeline Programs↗

5

Active Trials↗

1

Companies Involved↗

Metastases is an early-stage landscape with 0 programs across 1 company. The most active players are Aura Biosciences.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Aura Biosciences

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed9 · 60%
Recruiting3 · 20%
Not yet recruiting2 · 13%
Withdrawn1 · 7%

Clinical Trials

Trial Activity

15 trials

Suprachoroidal Administration in Subjects With Metastases to the Choroid
Recruiting·AAura Biosciences·Phase 2·NCT06643884·24 enrolled
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
Recruiting·UUniversity Health Network, Toronto·Phase 1·NCT02811523·17 enrolled
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
Recruiting·—·Phase 1/2·NCT03685890·74 enrolled
PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
Not yet recruiting·—·Phase 1·NCT07411781·25 enrolled
Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment
Not yet recruiting·FFudan University·Phase 2·NCT05717582·47 enrolled
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
Completed·UUNICANCER·Phase 2·NCT01442935·256 enrolled
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Completed·SStanford University·Phase 2·NCT00375830·114 enrolled
A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases
Completed·MMediGene·Phase 2·NCT00542048·20 enrolled
Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
Completed·RRockefeller University·Phase 1·NCT01711684·6 enrolled
Calcium Electroporation for Treatment of Cutaneous Metastases
Completed·HHerlev Hospital·Phase 2·NCT01941901·7 enrolled
Photodynamic Therapy for the Treatment of Vertebral Metastases
Completed·SSunnybrook Health Sciences Centre·Phase 1·NCT02464761·30 enrolled
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
Completed·NNYU Langone Health·N/A·NCT00012168
Study of Topical SOR007 Ointment for Cutaneous Metastases
Completed·NNanOlogy, LLC·Phase 1/2·NCT03101358·23 enrolled
Effect of Samarium on the Relief of Pain Due to Vertebral Metastases
Completed·NNew York Presbyterian Brooklyn Methodist Hospital·Phase 1/2·NCT00374751·29 enrolled
IXO+A in mCRC With Liver-only Metastases
Withdrawn·OOttawa Hospital Research Institute·Phase 2·NCT01293942

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)